col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


137 Results       Page 1

 [1] 
BMJ: Gut
  original article Date Title Authors   All Authors
1 [GO] 2024―May―17 SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease
2 [GO] 2023―Dec―12 Productive infection of primary human hepatocytes with SARS-CoV-2 induces antiviral and proinflammatory responses Natalie Heinen, Rajendra Khanal, Saskia Westhoven, Mara Klöhn, Simon T Herrmann, Maike Herrmann, et al. (+9)
3 [GO] 2023―Sep―22 Exploring the impact of gut microbial metabolites on inactivated SARS-CoV-2 vaccine efficacy during pregnancy and mother-to-infant antibody transfer Xi Fu, Bingqian Du, Pei-An Chen, Aga Shama, Baolan Chen, Xi Zhang, et al. (+14)
4 [GO] 2023―Jul―27 B and T cell responses to the BNT162b2 COVID-19 mRNA vaccine are not impaired in germ-free or antibiotic-treated mice Todd Norton, Miriam Anne Lynn, Charné Rossouw, Arunasingam Abayasingam, Griffith Perkins, Pravin Hissaria, et al. (+2)
5 [GO] 2023―Jul―24 Temporal trend of mortality in patients with cirrhosis with primary biliary cholangitis and primary sclerosing cholangitis during the COVID-19 pandemic Xinyuan He, Ning Gao, Fan Lv, Fengping Wu, Yi Liu, Lamei Li, et al. (+3)
6 [GO] 2023―Jun―14 SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease Hendrik Luxenburger, Robert Thimme
7 [GO] 2023―Mar―16 Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments Eva Zhang, Thi H O Nguyen, Lilith F Allen, Lukasz Kedzierski, Louise C Rowntree, So Young Chang, et al. (+10)
8 [GO] 2023―Jan―30 Inflammation-associated gut microbiome in postacute sequelae of SARS-CoV-2 points towards new therapeutic targets Valdirene Leao Carneiro, Katherine M Littlefield, Renee Watson, Brent E Palmer, Catherine Lozupone
9 [GO] 2022―Dec―22 Gut microbiome and dietary fibre intake strongly associate with IgG function and maturation following SARS-CoV-2 mRNA vaccination Genelle Rose Healey, Liam Golding, Alana Schick, Abdelilah Majdoubi, Pascal M Lavoie, Bruce Andrew Vallance
10 [GO] 2022―Dec―09 Post COVID-19 irritable bowel syndrome Giovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, Giulia Cacciari, Francesca Falangone, Anna Kagramanova, et al. (+61)
11 [GO] 2022―Dec―02 Correction:Comparison between non-pulmonary and pulmonary immune responses in a HIV decedent who succumbed to COVID-19
12 [GO] 2022―Nov―09 Health-code-based triage versus universal COVID-19 PCR testing before endoscopy in a low incidence area: a real-world experience Zhihui Duan, Dengxiang Liu, Shengyun Zhou, Hui Li, Xiaofang Sun, Chunqian Zhao, et al. (+4)
13 [GO] 2022―Oct―24 Correction:Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19
14 [GO] 2022―Oct―07 Dynamic changes in host immune system and gut microbiota are associated with the production of SARS-CoV-2 antibodies Maozhen Han, Yixuan Huang, Hongya Gui, Yixuan Xiao, Maozhang He, Jiling Liu, et al. (+12)
15 [GO] 2022―Oct―04 Great escape: how infectious SARS-CoV-2 avoids inactivation by gastric acidity and intestinal bile Malak A Esseili
16 [GO] 2022―Sep―16 SARS-CoV-2 Omicron variant infection was associated with higher morbidity in patients with cirrhosis Anand V Kulkarni, Chandan S Metage, Baqar Ali Gora, Sowmya Tirumalle, Kalyan Rakam, Anveshi Satyavadi, et al. (+5)
17 [GO] 2022―Sep―05 Most excess years of potential life loss among individuals with cirrhosis during the pandemic were not related to COVID-19 Yunyu Zhao, Yee Hui Yeo, Jamil Samaan, Fan Lv, Xinyuan He, Ning Gao, et al. (+6)
18 [GO] 2022―Sep―05 COVID-19 vaccine effectiveness and community prevalence of Alpha, Delta and Omicron variants in patients with cirrhosis Binu V John, Dustin R Bastaich, Raphaella D Ferreira, Akash Doshi, Tamar H Taddei, David E Kaplan, et al. (+3)
19 [GO] 2022―Sep―05 British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance Antonia MD Churchhouse, Victoria EL Moffat, Christian P Selinger, Christopher A Lamb, Michelle J Thornton, Ian Penman, Shahida Din
20 [GO] 2022―Aug―23 Single-cell gene expression links SARS-CoV-2 infection and gut serotonin Alyce M Martin, Michael Roach, Lauren A Jones, Daniel Thorpe, Rosemary A Coleman, Caitlin Allman, et al. (+2)
21 [GO] 2022―Aug―08 Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2 clearance Qi Su, Raphaela Iris Lau, Qin Liu, Francis Ka Leung Chan, Siew Chien Ng
22 [GO] 2022―Jul―28 COVID-19 and liver injury: hypoalbuminaemia and γGT should be observed at hospital admission Sabine Weber, Alexander L Gerbes
23 [GO] 2022―Jul―28 Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic Nicholas A Kennedy, Malik Janjua, Neil Chanchlani, Simeng Lin, Claire Bewshea, Rachel Nice, et al. (+17)
24 [GO] 2022―Jul―28 SARS-CoV-2 vaccination in patients with GI and hepatobiliary carcinoma: a call for booster vaccination Malte Benedikt Monin, Leona Baier, Moritz Berger, Jens Gabriel Gorny, Taotao Zhou, Robert Mahn, et al. (+8)
25 [GO] 2022―Jul―07 Impact of pre-procedural testing on SARS-CoV-2 transmission to endoscopy staff Alexander Hann, Sven Flemming, Stanislaus Reimer, Kaja Groneberg, Theodor Kudlich, Christoph-Thomas Germer, Alexander Meining
26 [GO] 2022―Jun―14 COVID-19 and liver disease Jean-François Dufour, Thomas Marjot, Chiara Becchetti, Herbert Tilg
27 [GO] 2022―May―23 Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic Simeng Lin, Louis HS Lau, Neil Chanchlani, Nicholas A Kennedy, Siew C Ng
28 [GO] 2022―May―23 Mechanistic insight of SARS-CoV-2 infection using human hepatobiliary organoids Yi Zhao, Xiaoxue Ren, Jing Lu, Minghui He, Zhe Liu, Lina Yi, et al. (+7)
29 [GO] 2022―May―23 Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease Joshua Quan, Christopher Ma, Remo Panaccione, Lindsay Hracs, Nastaran Sharifi, Michelle Herauf, et al. (+13)
30 [GO] 2022―May―05 Withdrawal of the British Society of Gastroenterology IBD risk grid for COVID-19 severity Charlie W Lees, Tariq Ahmad, Christopher Andrew Lamb, Nick Powell, Shahida Din, Rachel Cooney, et al. (+4)
31 [GO] 2022―Apr―08 Correction: PTH-60 Impact of SARS-CoV-2 pandemic on the IBD advice line- a single centre experience
32 [GO] 2022―Feb―10 Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial Christina M Brennan, Sandeep Nadella, Xiang Zhao, Richard J Dima, Nicole Jordan-Martin, Breanna R Demestichas, et al. (+25)
33 [GO] 2022―Feb―09 Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events Siew C Ng, Ye Peng, Lin Zhang, Chris KP Mok, Shilin Zhao, Amy Li, et al. (+11)
34 [GO] 2022―Feb―08 Gut microbiota changes are detected in asymptomatic very young children with SARS-CoV-2 infection Lydia Nashed, Jyoti Mani, Sahel Hazrati, David B Stern, Poorani Subramanian, Lisa Mattei, et al. (+5)
35 [GO] 2022―Jan―31 High antibody response in relation to immunosuppressive blood levels in liver transplant recipients after SARS-CoV-2 vaccination: an observational, cohort study Midas B Mulder, Annemiek A van der Eijk, Corine H GeurtsvanKessel, Nicole S Erler, Brenda C M de Winter, Wojciech G Polak, et al. (+2)
36 [GO] 2022―Jan―26 Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome Qin Liu, Joyce Wing Yan Mak, Qi Su, Yun Kit Yeoh, Grace Chung-Yan Lui, Susanna So Shan Ng, et al. (+7)
37 [GO] 2022―Jan―17 SARS-CoV-2 pandemic has impacted on patterns of aetiology for acute pancreatitis and management of gallstone pancreatitis in the UK Chris Varghese, Manu Nayar, Sanjay Pandanaboyana
38 [GO] 2022―Jan―05 Humoral response to SARS-CoV-2 infection among liver transplant recipients Chiara Becchetti, Annelotte G C Broekhoven, Géraldine Dahlqvist, Montserrat Fraga, Marco Fabrizio Zambelli, Olga Ciccarelli, et al. (+10)
39 [GO] 2021―Dec―15 Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel disease Judith Wellens, Matthew Edmans, Uri Obolski, Colleen GC McGregor, Peter Simmonds, Marc Turner, et al. (+11)
40 [GO] 2021―Dec―08 Correction: PTH-27 Risk-stratified FIT for urgent colonoscopy in Lynch Syndrome: A clinical service throughout the COVID-19 pandemic
41 [GO] 2021―Dec―07 Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes Javier Ampuero, Ana Lucena, Manuel Hernández-Guerra, Isabel Moreno-Moraleda, Juan Arenas, Isabel Conde, et al. (+18)
42 [GO] 2021―Nov―24 Risk of adverse events and reported clinical relapse after COVID-19 vaccination in patients with IBD Rosanna Cannatelli, Francesca Ferretti, Stefania Carmagnola, Irene Maria Bambina Bergna, Maria Camilla Monico, Giovanni Maconi, Sandro Ardizzone
43 [GO] 2021―Nov―23 Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapy Zahra Jama Shire, Frederic Reicherz, Sally Lawrence, Harjeev Sudan, Liam Golding, Abdelilah Majdoubi, et al. (+3)
44 [GO] 2021―Nov―11 Clinical characteristics, hospitalisation and mortality rates of COVID-19 among patients with coeliac disease in the USA: a multicentre network study Emad Mansoor, Muhammed Mustafa Alikhan, Jaime Abraham Perez, Kayla Schlick, Mohannad Abou Saleh, Alberto Rubio-Tapia
45 [GO] 2021―Nov―11 SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study Manu Nayar, Chris Varghese, Aditya Kanwar, Ajith K Siriwardena, Ali Raza Haque, Altaf Awan, et al. (+46)
46 [GO] 2021―Oct―18 Proton-pump inhibitor use is not associated with severe COVID-19-related outcomes: a propensity score-weighted analysis of a national veteran cohort Shailja Shah, Alese Halvorson, Brandon McBay, Chad Dorn, Otis Wilson, Sony Tuteja, et al. (+10)
47 [GO] 2021―Oct―07 Correction: Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System
48 [GO] 2021―Sep―06 Diet quality and risk and severity of COVID-19: a prospective cohort study Jordi Merino, Amit D Joshi, Long H Nguyen, Emily R Leeming, Mohsen Mazidi, David A Drew, et al. (+24)
49 [GO] 2021―Aug―10 Comparison between non-pulmonary and pulmonary immune responses in a HIV decedent who succumbed to COVID-19 Denise Goh, Justina Nadia Lee, Tracy Tien, Jeffrey Chun Tatt Lim, Sherlly Lim, An Sen Tan, et al. (+3)
50 [GO] 2021―Aug―02 Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study Gilaad G Kaplan, Christopher Ma, Carmen Charlton, Jamil N Kanji, Graham Tipples, Nastaran Sharifi, et al. (+6)
51 [GO] 2021―Jul―19 COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study Luca Saverio Belli, Christophe Duvoux, Paolo Angelo Cortesi, Rita Facchetti, Speranta Iacob, Giovanni Perricone, et al. (+40)
52 [GO] 2021―Jul―12 Correction: A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis
53 [GO] 2021―Jul―06 Rapid resolution of COVID-19 after faecal microbiota transplantation Jarosław Biliński, Katarzyna Winter, Marcin Jasiński, Anna Szczęś, Natalia Bilinska, Benjamin H Mullish, et al. (+2)
54 [GO] 2021―Jun―17 Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: another collateral damage of the COVID-19 pandemic? Esra Görgülü, Wenyi Gu, Jonel Trebicka, Victoria Therese Mücke, Marcus Maximilian Muecke, Mireen Friedrich-Rust, et al. (+4)
55 [GO] 2021―Jun―15 Duality of the association between COVID-19 and acute pancreatitis Xiu-He Lv, Kai Deng, Jin-Lin Yang
56 [GO] 2021―Jun―11 SARS-COV-2 in endoscopy: still a long way to go Maria Valeria Matteo, Ivo Boškoski, Guido Costamagna
57 [GO] 2021―Jun―03 Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19 Chun Chau Lawrence Cheung, Denise Goh, Xinru Lim, Tracy Zhijun Tien, Jeffrey Chun Tatt Lim, Justina Nadia Lee, et al. (+16)
58 [GO] 2021―Jun―03 Liver injury, hypoalbuminaemia and severe SARS-CoV-2 infection Clare Elizabeth Foley, Christopher Mulvey, Maria Boylan, Niamh Reidy, Paul Reidy, David Moynan, et al. (+5)
59 [GO] 2021―May―25 Correction: Gastroenterology department operational reorganisation at the time of COVID-19 outbreak: an Italian and Chinese experience
60 [GO] 2021―May―05 SARS-CoV-2 in endoscopy: a potential way of microorganisms’ air transmission Stanislas Chaussade, Rachel Hallit, Einas Abou Ali, Arthur Belle, Maximilien Barret, Romain Coriat
61 [GO] 2021―Apr―26 Gut as viral reservoir: lessons from gut viromes, HIV and COVID-19 Markus F Neurath, Klaus Überla, Siew C Ng
62 [GO] 2021―Apr―26 Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD Nicholas A Kennedy, Simeng Lin, James R Goodhand, Neil Chanchlani, Benjamin Hamilton, Claire Bewshea, et al. (+20)
63 [GO] 2021―Apr―08 Six-month follow-up of gut microbiota richness in patients with COVID-19 Yanfei Chen, Silan Gu, Yunbo Chen, Haifeng Lu, Ding Shi, Jing Guo, et al. (+17)
64 [GO] 2021―Mar―31 Enhanced donor screening for faecal microbial transplantation during COVID-19 Seema Nair Parvathy, John G Lenehan, Ricardo Fernandes, Susan M Poutanen, Susy Hota, Saman Maleki Vareki, Michael Silverman
65 [GO] 2021―Mar―31 Alterations in the human oral and gut microbiomes and lipidomics in COVID-19 Zhigang Ren, Haiyu Wang, Guangying Cui, Haifeng Lu, Ling Wang, Hong Luo, et al. (+19)
66 [GO] 2021―Mar―24 COVID-19 transmission following outpatient endoscopy during pandemic acceleration phase involving SARS-CoV-2 VOC 202012/01 variant in UK Bu'Hussain Hayee, Pradeep Bhandari, Colin J Rees, Ian Penman
67 [GO] 2021―Mar―22 Risk factors for SARS-CoV-2 infection and course of COVID-19 disease in patients with IBD in the Veterans Affair Healthcare System Nabeel Khan, Nadim Mahmud, Chinmay Trivedi, Walter Reinisch, James D Lewis
68 [GO] 2021―Mar―05 SARS-CoV-2 transmission via endoscopy in the COVID-19 era Theodor Alexandru Voiosu, Claudia Irina Puscasu, Andrei Voiosu
69 [GO] 2021―Mar―03 Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology? Mohamed Attauabi, Jakob Seidelin, Johan Burisch
70 [GO] 2021―Feb―12 Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic Colleen GC McGregor, Alex Adams, Ross Sadler, Carolina V Arancibia-Cárcamo, Rebecca Palmer, Tim Ambrose, et al. (+7)
71 [GO] 2021―Feb―07 SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study Sanjay Pandanaboyana, John Moir, John S Leeds, Kofi Oppong, Aditya Kanwar, Ahmed Marzouk, et al. (+50)
72 [GO] 2021―Feb―05 COVID-19 and endoscopic services: the impact of delays in therapeutic colonoscopies on patients Syazeddy Samani, Nasir Mir, David N Naumann, Michael Ding, Sharad Karandikar, Jason Goh, et al. (+3)
73 [GO] 2021―Feb―01 Intraductal bile duct stents should be prioritised for removal during the pandemic Wafaa Ahmed, Deepak Joshi, Phillip Harrison, David Reffitt, John Devlin
74 [GO] 2021―Jan―29 Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study Sabine Weber, Johannes C Hellmuth, Clemens Scherer, Maximilian Muenchhoff, Julia Mayerle, Alexander L Gerbes
75 [GO] 2021―Jan―20 SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting Corey A Siegel, Gil Y Melmed, Dermot PB McGovern, Victoria Rai, Florian Krammer, David T Rubin, et al. (+2)
76 [GO] 2021―Jan―12 Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19 Yun Kit Yeoh, Tao Zuo, Grace Chung-Yan Lui, Fen Zhang, Qin Liu, Amy YL Li, et al. (+18)
77 [GO] 2021―Jan―06 Endoscopes used in positive and critically ill patients are SARS-CoV-2 negative at virological assessment Ivo Boškoski, Anna Di Gemma, Maria Valeria Matteo, Fabio Grilli, Paola Cattani, Guido Costamagna
78 [GO] 2021―Jan―05 Serotonin is elevated in COVID-19-associated diarrhoea Seeun Ha, Byungchang Jin, Brooke Clemmensen, Paul Park, Sumaiya Mahboob, Vadim Gladwill, et al. (+5)
79 [GO] 2020―Dec―31 Aerosol generation and droplet spread during nasogastric intubation in the COVID-19 era Wout Verbeure, Annelies Geeraerts, I-Hsuan Huang, Lien Timmermans, Joran Toth, Hannelore Geysen, et al. (+8)
80 [GO] 2020―Dec―17 Clinical, financial and academic implications of COVID-19 on a tertiary care interventional endoscopy programme Ji Young Bang, Robert Hawes, Shyam Varadarajulu
81 [GO] 2020―Dec―10 Proton pump inhibitors and the risk of severe COVID-19: a post-hoc analysis from the Korean nationwide cohort Seung Won Lee, Jee Myung Yang, In Kyung Yoo, Sung Yong Moon, Eun Kyo Ha, Abdullah Özgür Yeniova, et al. (+4)
82 [GO] 2020―Dec―05 Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study Jiandong Zhou, Xiansong Wang, Sharen Lee, William Ka Kei Wu, Bernard Man Yung Cheung, Qingpeng Zhang, Gary Tse
83 [GO] 2020―Nov―20 COVID-19 and IBD drugs: should we change anything at the moment? Charlie W Lees, Peter M Irving, Laurent Beaugerie
84 [GO] 2020―Nov―10 Do proton pump inhibitors influence SARS-CoV-2 related outcomes? A meta-analysis Guo-Fu Li, Xiao-Xiao An, Yichao Yu, Li-Rong Jiao, Daniele Canarutto, Guo Yu, et al. (+3)
85 [GO] 2020―Nov―06 Mandatory preprocedure testing for SARS-CoV-2 for all-comers may not be required for resuming endoscopic services amidst the ongoing COVID-19 pandemic Soumya Jagannath, Ashish Agarwal, Deepak Gunjan, Samir Mohindra, Vishal Sharma, Sudipta Dhar Chowdhury, et al. (+4)
86 [GO] 2020―Oct―20 Effect of IBD medications on COVID-19 outcomes: results from an international registry Ryan C Ungaro, Erica J Brenner, Richard B Gearry, Gilaad G Kaplan, Michele Kissous-Hunt, James D Lewis, et al. (+8)
87 [GO] 2020―Oct―07 Combination of CLIF-OF and CCI predicts survival in patients with cirrhosis and COVID-19 Massimo Iavarone, Roberta D'Ambrosio, Pietro Lampertico
88 [GO] 2020―Sep―28 Effects of SARS-CoV-2 emergency measures on high-risk lesions detection: a multicentre cross-sectional study Manuele Furnari, Leonardo Henry Eusebi, Edoardo Savarino, Carlo Petruzzellis, Gianluca Esposito, Marcello Maida, et al. (+9)
89 [GO] 2020―Sep―14 Multicentre prospective study of COVID-19 transmission following outpatient GI endoscopy in the UK Bu'Hussain Hayee, James East, Colin J Rees, Ian Penman
90 [GO] 2020―Sep―01 Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel Richard Hansen, Susanna Meade, R Mark Beattie, Marcus KH Auth, Nick Croft, Philip Davies, et al. (+15)
91 [GO] 2020―Aug―28 Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study Chey Loveday, Amit Sud, Michael E Jones, John Broggio, Stephen Scott, Firza Gronthound, et al. (+16)
92 [GO] 2020―Aug―26 COVID-19 and its impact on endoscopy services: what is the threshold for missed malignant diagnosis? Tony He, Michael B MacIsaac, Simon J Hume, Alexander J Thompson, Julien D Schulberg
93 [GO] 2020―Aug―21 COVID-19 in patients with cirrhosis: understanding adverse impact Sanchit Sharma, Anshuman Elhence, Manas Vaishnav, Ramesh Kumar
94 [GO] 2020―Aug―18 Modulating immunosuppression in liver transplant patients with COVID-19 Manuel Rodriguez-Peralvarez, Magdalena Salcedo, Jordi Colmenero, Jose Antonio Pons
95 [GO] 2020―Aug―14 Recovery of endoscopy services in the era of COVID-19: recommendations from an international Delphi consensus Pradeep Bhandari, Sharmila Subramaniam, Michael J Bourke, Asma Alkandari, Philip Wai Yan Chiu, James F Brown, et al. (+32)
96 [GO] 2020―Jul―30 Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching Seung Won Lee, Eun Kyo Ha, Abdullah Özgür Yeniova, Sung Yong Moon, So Young Kim, Hyun Yong Koh, et al. (+6)
97 [GO] 2020―Jul―20 Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19 Tao Zuo, Qin Liu, Fen Zhang, Grace Chung-Yan Lui, Eugene YK Tso, Yun Kit Yeoh, et al. (+5)
98 [GO] 2020―Jul―20 Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database Analysis Matthew D Rutter, Matthew Brookes, Thomas J Lee, Peter Rogers, Linda Sharp
99 [GO] 2020―Jul―15 Involvement of liver in COVID-19: systematic review and meta-analysis Dipesh Kumar Yadav, Akanand Singh, Qi Zhang, Xueli Bai, Wei Zhang, Rajesh Kumar Yadav, et al. (+4)
100 [GO] 2020―Jul―13 Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort Jasmohan S Bajaj, Guadalupe Garcia-Tsao, Scott Biggins, Patrick S Kamath, Florence Wong, Sara McGeorge, et al. (+11)
101 [GO] 2020―Jul―08 Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19 Terry Cheuk-Fung Yip, Grace Chung-Yan Lui, Vincent Wai-Sun Wong, Viola Chi-Ying Chow, Tracy Hang-Yee Ho, Timothy Chun-Man Li, et al. (+4)
102 [GO] 2020―Jul―03 Alteration of taste or smell as a predictor of COVID-19 Jyh-Ming Liou, Mei-Jyh Chen, Tzu-Chan Hong, Ming-Shiang Wu
103 [GO] 2020―Jul―03 Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic Gianluca Ianiro, Benjamin H Mullish, Colleen R Kelly, Zain Kassam, Ed J Kuijper, Siew C Ng, et al. (+19)
104 [GO] 2020―Jun―30 GI symptoms and fever increase the risk of severe illness and death in patients with COVID-19 Jue Liu, Liyuan Tao, Xia Liu, Hongyan Yao, Shicheng Yu, Qiqi Wang, et al. (+5)
105 [GO] 2020―Jun―22 Risk factors in patients with COVID-19 developing severe liver injury during hospitalisation Ke Zhan, Shengtao Liao, Jinfang Li, Yang Bai, Lin Lv, Keqi Yu, et al. (+5)
106 [GO] 2020―Jun―22 COVID-19 in an international European liver transplant recipient cohort Chiara Becchetti, Marco Fabrizio Zambelli, Luisa Pasulo, Maria Francesca Donato, Federica Invernizzi, Olivier Detry, et al. (+16)
107 [GO] 2020―Jun―22 Management strategies for the colonoscopic surveillance of people with Lynch syndrome during the COVID-19 pandemic Kevin J Monahan, Anne Lincoln, James E East, Sally Benton, John Burn, Bianca DeSouza, et al. (+7)
108 [GO] 2020―Jun―17 Infliximab for severe ulcerative colitis and subsequent SARS-CoV-2 pneumonia: a stone for two birds Cristina Bezzio, Gianpiero Manes, Francesco Bini, Lucienne Pellegrini, Simone Saibeni
109 [GO] 2020―Jun―08 Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel Shahida Din, Alexandra Kent, Richard C Pollok, Susanna Meade, Nicholas A Kennedy, Ian Arnott, et al. (+28)
110 [GO] 2020―Jun―05 Safely restarting GI endoscopy in the era of COVID-19 Bu'Hussain Hayee, Mo Thoufeeq, Colin J Rees, Ian Penman, James East
111 [GO] 2020―Jun―05 Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series Tobias Janowitz, Eva Gablenz, David Pattinson, Timothy C Wang, Joseph Conigliaro, Kevin Tracey, David Tuveson
112 [GO] 2020―Jun―04 One world, one pandemic, many guidelines: management of liver diseases during COVID-19 Steven Bollipo, Devika Kapuria, Atoosa Rabiee, Gil Ben-Yakov, Rashid N Lui, Hye Won Lee, et al. (+4)
113 [GO] 2020―Jun―03 Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California John Gubatan, Steven Levitte, Akshar Patel, Tatiana Balabanis, Arpita Sharma, Elaina Jones, et al. (+5)
114 [GO] 2020―May―25 Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis Georgia Zeng, Upkar S Gill, Patrick T F Kennedy
115 [GO] 2020―May―20 Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study Xiaolong Qi, Yanna Liu, Jitao Wang, Jonathan Fallowfield, Jianwen Wang, Xinyu Li, et al. (+34)
116 [GO] 2020―May―19 Comparative study of the clinical characteristics and epidemiological trend of 244 COVID-19 infected children with or without GI symptoms Xiao-li Xiong, Kenneth Kak-yuen Wong, Shui-qing Chi, Ai-fen Zhou, Jian-qiao Tang, Li-shan Zhou, et al. (+16)
117 [GO] 2020―May―18 Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study Cristina Bezzio, Simone Saibeni, Angela Variola, Mariangela Allocca, Alessandro Massari, Viviana Gerardi, et al. (+24)
118 [GO] 2020―May―15 Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores Giovanni Targher, Alessandro Mantovani, Christopher D Byrne, Xiao-Bo Wang, Hua-Dong Yan, Qing-Feng Sun, et al. (+6)
119 [GO] 2020―May―14 GI symptoms as early signs of COVID-19 in hospitalised Italian patients Elisabetta Buscarini, Guido Manfredi, Gianfranco Brambilla, Fernanda Menozzi, Claudio Londoni, Saverio Alicante, et al. (+18)
120 [GO] 2020―May―11 The price of being a doctor during the COVID-19 outbreak Nicola Imperatore, Antonio Rispo, Giovanni Lombardi
121 [GO] 2020―Apr―23 Severe liver failure during SARS-CoV-2 infection Sabine Weber, Julia Mayerle, Michael Irlbeck, Alexander L Gerbes
122 [GO] 2020―Apr―22 Low risk of covid-19 transmission in GI endoscopy Alessandro Repici, Giovanni Aragona, Gianpaolo Cengia, Paolo Canté, Marco Spadaccini, Roberta Maselli, et al. (+5)
123 [GO] 2020―Apr―20 Faecal calprotectin indicates intestinal inflammation in COVID-19 Maria Effenberger, Felix Grabherr, Lisa Mayr, Julian Schwaerzler, Manfred Nairz, Markus Seifert, et al. (+9)
124 [GO] 2020―Apr―20 Covid-19 infection in Crohn’s disease under treatment with adalimumab Antonio Tursi, Gioacchino Angarano, Laura Monno, Annalisa Saracino, Fabio Signorile, Aurelia Ricciardi, Alfredo Papa
125 [GO] 2020―Apr―17 Covid-19 and immunomodulation in IBD Markus F Neurath
126 [GO] 2020―Apr―17 British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic Nicholas A Kennedy, Gareth-Rhys Jones, Christopher A Lamb, Richard Appleby, Ian Arnott, R Mark Beattie, et al. (+30)
127 [GO] 2020―Apr―16 Gastroenterology department operational reorganisation at the time of covid-19 outbreak: an Italian and Chinese experience Silvio Danese, Zhi Hua Ran, Alessandro Repici, Jinlu Tong, Paolo Omodei, Alessio Aghemo, Alberto Malesci
128 [GO] 2020―Apr―09 COVID-19 and the gastrointestinal tract: more than meets the eye Siew C Ng, Herbert Tilg
129 [GO] 2020―Apr―03 A fatal case of COVID-19 pneumonia occurring in a patient with severe acute ulcerative colitis Stefano Mazza, Andrea Sorce, Flora Peyvandi, Maurizio Vecchi, Flavio Caprioli
130 [GO] 2020―Apr―02 Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements) Philip Wai Yan Chiu, Siew C Ng, Haruhiro Inoue, D Nageshwar Reddy, Enqiang Ling Hu, Joo Young Cho, et al. (+11)
131 [GO] 2020―Apr―02 Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process Hao Zhang, Zijian Kang, Haiyi Gong, Da Xu, Jing Wang, Zhixiu Li, et al. (+8)
132 [GO] 2020―Apr―02 Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection Lu Lin, Xiayang Jiang, Zhenling Zhang, Siwen Huang, Zhenyi Zhang, Zhaoxiong Fang, et al. (+10)
133 [GO] 2020―Apr―02 Prevention of nosocomial SARS-CoV-2 transmission in endoscopy: international recommendations and the need for a gold standard John Ong, Gail B Cross, Yock Young Dan
134 [GO] 2020―Mar―25 Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms Xi Jin, Jiang-Shan Lian, Jian-Hua Hu, Jianguo Gao, Lin Zheng, Yi-Min Zhang, et al. (+40)
135 [GO] 2020―Mar―20 COVID-19 in gastroenterology: a clinical perspective John Ong, Barnaby Edward Young, Sharon Ong
136 [GO] 2020―Mar―05 SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19 Y Song, P Liu, X L Shi, Y L Chu, J Zhang, J Xia, et al. (+3)
137 [GO] 2020―Feb―26 Diarrhoea may be underestimated: a missing link in 2019 novel coronavirus Weicheng Liang, Zhijie Feng, Shitao Rao, Cuicui Xiao, Xingyang Xue, Zexiao Lin, et al. (+2)
 [1] 

137 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec